73 research outputs found
Molecular analysis has allowed the definitive diagnosis of multiple acyl-CoA dehydrogenase deficiency (MADD)
Multiple acyl-CoA dehydrogenation deficiency (MADD) is a rare autosomal recessive disorder due to defects in the electron transfer
flavoprotein (ETF) or in the electron transfer flavoprotein dehydrogenase (ETFDH) enzymes, involved in the mitochondrial electron
transport chain. Patients with MADD fall into different clinical phenotypes, ranging from a severe neonatal presentation, with metabolic
acidosis, cardiomyopathy and liver disease to a mild childhood/adult disease, with episodic metabolic decompensation, muscle weakness
and respiratory failure.Nowadays, the MADD diagnosis is established by the presence of dicarboxylic organic acids and acylglycine
derivatives in the urine and increased levels of medium-and long-chain acylcarnitines in the blood. Mutations in ETFA, ETFB, ETFDH
genes, encoding for alpha and beta subunits of ETF and for ETF-dehydrogenase are associated with MADD. We report the case of a three
years old child, affected by lethargy and asthenia associated with anorexia. Biochemical analyses showed hypoketotic hypoglycemia with
remarkable increments in transaminases, lactic dehydrogenase, aldolase and creatine kinase. The chromatographic layout of urinary
organic acids showed a typical dicarboxylic aciduria. Thus, based on these features, MADD was suspected. Fifteen years later, at the
age of 19, MADD diagnosis was confirmed by molecular analysis, showing a compound heterozygosity for the mutations c.1074G>C
(p.R358S; HGMD: CM031670 in HGMD database) and c.1073G>A (p.R358K) in the ETFDH gene. The c.1073G>A (p.R358K;
rs796051959) mutation is reported in ClinVar database as pathogenic allele, although lacking link to a specific clinical condition. However,
familial segregation study and in silico analysis, performed by bioinformatics tools, confirmed that this substitution is likely pathogenetic.
Her parents were healthy carriers of one of the two mutations. It is known that the severity of the clinical phenotype of MADD may
be related to the type of mutation in the ETFA/ETFB/ETFDH genes. Particularly, missense mutations in the ETFDH gene, leaving a
detectable residual enzyme activity, may account for the milder form of the disease, as is the case here. In conclusion we suggest that
molecular analysis is essential to the definitive diagnosis of MADD and to direct the adequate therapeutic management. Thus, through
a close nutritional follow up, a few months ago the patient gave birth to a healthy boy.
References
Olsen et al. Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation
deficiency. Hum Mutat. 2003; 22:12–23
A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media tickness in middle-aged women.
Genetic pre-participation screening in selected athletes: a new tool for the prevention of sudden cardiac death?
Sudden cardiac death (SCD) of athletes is a
topical issue. “Borderline cardiac abnormalities”, which occur in
~2% of elite male athletes, may result in SCD, which may have
a genetic base. Genetic analysis may help identify pathological
cardiac abnormalities. We performed phenotype-guided
genetic analysis in athletes who, pre-participation, showed
ECG and/or echo “borderline” abnormalities, to discriminate
subjects at a greater risk of SCD.
Methods: We studied 24 elite athletes referred by the National
Federation of Olympic sports; and 25 subjects seeking eligibility
to practice agonistic sport referred by the Osservatorio
Epidemiologico della Medicina dello Sport della Regione
Campania. Inclusion criteria: a) ECG repolarization borderline
abnormalities; b) benign ventricular arrhythmias; c) left
ventricular wall thickness in the grey zone of physiology versus
pathology (max wall thickness 12-15 mm in females; 13-16 mm
in males). Based on the suspected phenotype, we screened
subjects for the LMNA gene, for 8 sarcomeric genes, 5
desmosomal genes, and cardiac calcium, sodium and
potassium channel disease genes.
Results: Genetic analysis was completed in 37/49 athletes, 22
competitive and 27 non-competitive athletes, showing
“borderline” clinical markers suggestive of hypertrophic
cardiomyopathy (HCM,n. 24), dilated cardiomyopathy (n. 4),
arrhythmogenic right ventricular dysplasia/cathecholaminergic
polymorphic ventricular tachycardia (ARVD/CPVT, n. 11), long
QT syndrome (LQTS, n. 4), sick sinus syndrome (SSS, n. 5),
Brugada syndrome (BrS, n. 1). We identifyed 11 mutations in
9 athletes (an ARVD athlete was compound heterozygote for
the PKP2 gene and an HCM athlete was double heterozygote
for the MYBPC3 and TNNT2 genes): 3 known mutations
related to LQTS, HCM and ARVD, respectively, and 8 novel
mutations, located in the SCN5A, RyR2, PKP2, MYBPC3 and
ACTC1 genes. The new mutations were absent in ~800 normal
chromosomes and were predicted “probably damaging” by in
silico analysis. Patch clamp analysis in channelopathies
indicated for some mutation abnormal biophysical behavior of
the corresponding mutant protein.
Conclusion: Genetic analysis may help distinguish between
physiology and pathology in athletes with clinically suspected
heart disease
A new case of Congenital Hyperinsulinemic Hypoglycemia due to M/SCHAD deficiency: the contribution of metabolic and molecular diagnosis for the management
Congenital Hyperinsulinemic Hypoglycemia (CHH) is a rare metabolic disease (prevalence <1/1.000.000) characterized by a persistent
hypoglycemia and high secretion of insulin in the neonatal and infancy period. An early management of patients with CHH is mandatory to
avoid brain damage. Recent advances in molecular analysis have linked CHH to mutations in nine genes: ABCC8, KCNJ11, GCK causing
either diazoxide-responsive or diazoxide-unresponsive Hyperinsulinemic Hypoglycemia, and GLUD1, HADH, SLC16A1, UCP2, HNF4A
and HNF1A, causing generally diazoxide-responsive CHH. However, HADH defect is the most common form in presence of consanguinity
and diazoxide-responsiveness. The HADH gene codifies the M/SCHAD mitochondrial enzyme, which catalyses the penultimate reaction in
the β-oxidation of medium and short-chain fatty acids, causing in some affected individuals an elevated plasmatic hydroxybutyrylcarnitine
and urinary medium-chain dicarboxylic, and 3-hydroxydicarboxylic metabolites. To date about 40 cases of M/SCHAD defect have been
reported in literature.We report here a new case of CHH due to M/SCHAD deficiency. The index case was a Pakistan infant, born
from consanguineous parents, showing a diazoxide-responsive hyperinsulinism and organic aciduria. The M/SCHAD deficiency was
confirmed by the molecular diagnosis performed by sequencing of HADH gene, which revealed the presence of the nonsense mutation
c.706C>T (p.R236*) in HADH gene, at homozygous state, while both parents were heterozygous for the mutated allele. The patient
started diazoxide treatment at the maximum dose of 10 mg/kg/day, which resulted in adverse drug reactions (hypertrichosis, peripheral
edemas and persistent hypertension) gradually solved with antihypertensive regimen. Diazoxide was progressively titrated to 2 mg/kg/
day with good results in glycemic control and no hypertensive crisis. Low organic aciduria was followed.In conclusion, when the metabolic
profile suggests a CHH disorder, the molecular analysis is necessary for the precise diagnosis and the appropriate counseling to the
parents, also for the possibility of a prenatal diagnosis. In this setting, the definitive diagnosis of CHH, due to M/SCHAD deficiency, may
suggest also the most appropriate therapeutic intervention to avoid both risk of worsening or adverse drug effect
Physical activity and thrombophilic risk in a short series
The role of influence on protein C anticoagulant system and PC deficiency-related thrombophilic risk due to strenuous physical exercise is still under discussion. To investigate the modification of the protein C anticoagulant pathway after vigorous exercise, we measured ProC® Global assay, a protein C activity dependent clotting time, in 20 healthy subjects before and immediately after maximal treadmill exercise, and at 5, 15, 30 and 60 min in the recovery phase. The most evident change was a shortening of ProC® Global clotting time from the average basal value of 123 sec to 84 sec at 30 min in post-exercise. Our study shows that the coagulation unbalance observed after strenuous exercise and with no consequence in healthy individuals with normal PC level, could increase the thrombophilic risk in silent carriers of significant defects of the protein C system and occasionally trigger an episode of deep vein thrombosis
Mitochondrial diabetes in children: seek and you will find it
Maternally Inherited Diabetes and Deafness (MIDD) is a rare form of diabetes due to defects in mitochondrial DNA (mtDNA).
3243 A.G is the mutation most frequently associated with this condition, but other mtDNA variants have been linked with
a diabetic phenotype suggestive of MIDD. From 1989 to 2009, we clinically diagnosed mitochondrial diabetes in 11 diabetic
children. Diagnosis was based on the presence of one or more of the following criteria: 1) maculopathy; 2) hearing
impairment; 3) maternal heritability of diabetes/impaired fasting glucose and/or hearing impairment and/or maculopathy in
three consecutive generations (or in two generations if 2 or 3 members of a family were affected). We sequenced the
mtDNA in the 11 probands, in their mothers and in 80 controls. We identified 33 diabetes-suspected mutations, 1/33 was
3243A.G. Most patients (91%) and their mothers had mutations in complex I and/or IV of the respiratory chain. We
measured the activity of these two enzymes and found that they were less active in mutated patients and their mothers
than in the healthy control pool. The prevalence of hearing loss (36% vs 75–98%) and macular dystrophy (54% vs 86%) was
lower in our mitochondrial diabetic adolescents than reported in adults. Moreover, we found a hitherto unknown
association between mitochondrial diabetes and celiac disease. In conclusion, mitochondrial diabetes should be considered
a complex syndrome with several phenotypic variants. Moreover, deafness is not an essential component of the disease in
children. The whole mtDNA should be screened because the 3243A.G variant is not as frequent in children as in adults. In
fact, 91% of our patients were mutated in the complex I and/or IV genes. The enzymatic assay may be a useful tool with
which to confirm the pathogenic significance of detected variants
Metabolic Treatment of Wolfram Syndrome
Wolfram Syndrome (WS) is a very rare genetic disorder characterized by several symptoms that occur from childhood to adulthood. Usually, the first clinical sign is non-autoimmune diabetes even if other clinical features (optic subatrophy, neurosensorial deafness, diabetes insipidus) may be present in an early state and may be diagnosed after diabetes' onset. Prognosis is poor, and the death occurs at the median age of 39 years as a consequence of progressive respiratory impairment, secondary to brain atrophy and neurological failure. The aim of this paper is the description of the metabolic treatment of the WS. We reported the experience of long treatment in patients with this syndrome diagnosed in pediatric age and followed also in adult age. It is known that there is a correlation between metabolic control of diabetes, the onset of other associated symptoms, and the progression of the neurodegenerative alterations. Therefore, a multidisciplinary approach is necessary in order to prevent, treat and carefully monitor all the comorbidities that may occur. An extensive understanding of WS from pathophysiology to novel possible therapy is fundamental and further studies are needed to better manage this devastating disease and to guarantee to patients a better quality of life and a longer life expectancy
Dietary thiols: A potential supporting strategy against oxidative stress in heart failure and muscular damage during sports activity
Moderate exercise combined with proper nutrition are considered protective factors against cardiovascular disease and musculoskeletal disorders. However, physical activity is known not only to have positive effects. In fact, the achievement of a good performance requires a very high oxygen consumption, which leads to the formation of oxygen free radicals, responsible for premature cell aging and diseases such as heart failure and muscle injury. In this scenario, a primary role is played by antioxidants, in particular by natural antioxidants that can be taken through the diet. Natural antioxidants are molecules capable of counteracting oxygen free radicals without causing cellular cytotoxicity. In recent years, therefore, research has conducted numerous studies on the identification of natural micronutrients, in order to prevent or mitigate oxidative stress induced by physical activity by helping to support conventional drug therapies against heart failure and muscle damage. The aim of this review is to have an overview of how controlled physical activity and a diet rich in antioxidants can represent a “natural cure” to prevent imbalances caused by free oxygen radicals in diseases such as heart failure and muscle damage. In particular, we will focus on sulfur-containing compounds that have the ability to protect the body from oxidative stress. We will mainly focus on six natural antioxidants: Glutathione, taurine, lipoic acid, sulforaphane, garlic and methylsulfonylmethane
Childhood obesity: An overview of laboratory medicine, exercise and microbiome
In the last few years, a significant increase of childhood obesity incidence unequally distributed within countries and population groups has been observed, thus representing an important public health problem associated with several health and social consequences. Obese children have more than a 50% probability of becoming obese adults, and to develop pathologies typical of obese adults, that include type 2-diabetes, dyslipidemia and hypertension. Also environmental factors, such as reduced physical activity and increased sedentary activities, may also result in increased caloric intake and/or decreased caloric expenditure. In the present review, we aimed to identify and describe a specific panel of parameters in order to evaluate and characterize the childhood obesity status useful in setting up a preventive diagnostic approach directed at improving health-related behaviors and identifying predisposing risk factors. An early identification of risk factors for childhood obesity could definitely help in setting up adequate and specific clinical treatments
Exercise, immune system, nutrition, respiratory and cardiovascular diseases during COVID-19: A complex combination
Coronaviruses (CoVs) represent a large family of RNA viruses that can infect different living species, posing a global threat to human health. CoVs can evade the immune response, replicate within the host, and cause a rapid immune compromise culminating in severe acute respiratory syndrome. In humans, the immune system functions are influenced by physical activity, nutrition, and the absence of respiratory or cardiovascular diseases. This review provides an in-depth study between the interactions of the immune system and coronaviruses in the host to defend against CoVs disease
- …